A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

A preclinical study from scientists at Scripps Research finds that a apremilast, a drug already FDA-approved for treating ...

Mineralys plans to provide additional data from the pivotal Phase 3 Launch-HTN at an upcoming medical conference and in a peer-reviewed publication. Additionally, the ongoing Transform-HTN open-label ...

Epigenetic reprogramming holds promise for reversing aging, addressing cellular aging mechanisms and paving the way for innovative therapeutic strategies.

This useful study reports a method to detect and analyze a novel post-translational modification, lysine acetoacetylation (Kacac), finding it regulates protein metabolism pathways. The study unveils ...

A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may ...

Enter BIODYNAMIX® Joint Genesis™, a science-driven joint supplement created specifically for seniors dealing with discomfort, ...

As the agricultural industry faces new challenges and opportunities, companies like EW Nutrition play a crucial role in ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...